9 Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague

10 Identifying the social and environmental determinants of plague endemicity in Peru: insights from a case study in Ascope, La Libertad

11 Development of a simple and rapid immunochromatographic strip test for detecting duck plague virus antibodies based on gI protein

12 Ecological economics for humanity's plague phase

13 Plague and Pregnancy: Why Special Considerations Are Needed

14 Plague During Pregnancy: A Systematic Review

15 Human Plague - United States, 2015

16 Two Distinct Yersinia pestis Populations Causing Plague among Humans in the West Nile Region of Uganda

17 Antimicrobial Treatment of Human Plague: A Systematic Review of the Literature on Individual Cases, 1937–2019

18 Safety of Antimicrobials During Pregnancy: A Systematic Review of Antimicrobials Considered for Treatment and Postexposure Prophylaxis of Plague

19 Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report

20 A Plague on Your City: Observations from TOPOFF

21 Treatment of Human Plague: A Systematic Review of Published Aggregate Data on Antimicrobial Efficacy, 1939–2019

22 The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule

23 Plague: Still a Threat, but Evidence and Preparedness Are Keys to Fighting Back

24 Yersinia infections: centennial of the discovery of the plague bacillus

25 Yersinia pestis--etiologic agent of plague.

26 Modern therapy of plague

27 Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague

28 Levofloxacin Cures Experimental Pneumonic Plague in African Green Monkeys

29 Antimicrobial Treatment Patterns and Illness Outcome Among United States Patients With Plague, 1942–2018

30 Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

31 Plague: Past, Present, and Future

32 Reemergence of human plague in Yunnan, China in 2016

33 A plague on your city: observations from TOPOFF

34 Yersinia pestis--etiologic agent of plague

35 Plague: past, present, and future

36 Destroying the Life and Career of a Valued Physician-Scientist Who Tried to Protect Us from Plague: Was It Really Necessary?

37 MODERN THERAPY OF PLAGUE

38 Misidentification of Yersinia pestis by Automated Systems, Resulting in Delayed Diagnoses of Human Plague Infections—Oregon and New Mexico, 2010–2011

39 Levofloxacin cures experimental pneumonic plague in African green monkeys

40 Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania

41 Plazomicin is effective in a non-human primate pneumonic plague model

42 Treatment of Plague with Gentamicin or Doxycycline in a Randomized Clinical Trial in Tanzania

43 Yersinia Infections: Centennial of the Discovery of the Plague Bacillus

44 Epidemiology of human plague in the United States, 1900-2012

45 [Primary pneumonic plague with nosocomial transmission in La Libertad, Peru 2010]

46 Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation

47 Impact of plague on human history

48 Gentamicin and Tetracyclines for the Treatment of Human Plague: Review of 75 Cases in New Mexico, 1985–1999

49 facing the plague: economic and political inequality

50 surveillance and response: integrated indigenous health systems-based sentinel detection of human plague in a plague endemic west nile region of uganda (2008-2013)

51 surveillance and diagnosis of plague and anthrax in tanzania and zambia

52 small todents fleas from the bubonic plague focus located in the serra dos Órgãos mountain range, state of rio de janeiro, brazil

53 nikias, crete and the plague

54 news reports about health: between heroes and plagues

55 Flea diversity as an element for persistence of plague bacteria in an East African plague focus

56 Two Distinct Yersinia pestis Populations Causing Plague among Humans in the West Nile Region of Uganda

57 Treatment of bubonic plague with sulfonamides and antibiotics

58 Spatial risk models for human plague in the West Nile region of Uganda

59 In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis

60 [Why does the Ebola virus epidemic continue to plague the Democratic Republic of the Congo?]

61 Plague manual--epidemiology, distribution, surveillance and control

62 Differential plague-transmission dynamics determine Yersinia pestis population genetic structure on local, regional, and global scales

63 Diverse Genotypes of Yersinia pestis Caused Plague in Madagascar in 2007

64 Ecology of Yersinia pestis and the Epidemiology of Plague

65 Flea diversity and infestation prevalence on rodents in a plague-endemic region of Uganda

66 Genotyping and phylogenetic analysis of Yersinia pestis by MLVA: insights into the worldwide expansion of Central Asia plague foci

67 Assessing Human Risk of Exposure to Plague Bacteria in Northwestern Uganda Based on Remotely Sensed Predictors

68 Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999

69 Plague: A Clinical Review of 27 Cases

70 Natural history of plague: perspectives from more than a century of research

71 From the Cover: Differential plague-transmission dynamics determine Yersinia pestis population genetic structure on local, regional, and global scales

72 Human plague occurrences in Africa: an overview from 1877 to 2008

73 Chromosomal rearrangement features of Yersinia pestis strains from natural plague foci in China

74 Human plague occurrences in Africa: an overview from 1877 to 2008

75 A theatrical "chronicle" of the contagion. The Neapolitan plague of 1656 in Carlo Rota's languishing Partenope

Keyword Connections

Journals

Research Groups

Bibliographies